Modeling osteoporosis to design and optimize pharmacological therapies comprising multiple drug types

For the treatment of postmenopausal osteoporosis, several drug classes with different mechanisms of action are available. Since only a limited set of dosing regimens and drug combinations can be tested in clinical trials, it is currently unclear whether common medication strategies achieve optimal b...

Descripción completa

Detalles Bibliográficos
Autores principales: Jörg, David J, Fuertinger, Doris H, Cherif, Alhaji, Bushinsky, David A, Mermelstein, Ariella, Raimann, Jochen G, Kotanko, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: eLife Sciences Publications, Ltd 2022
Materias:
Computational and Systems Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9363122/
https://www.ncbi.nlm.nih.gov/pubmed/35942681
http://dx.doi.org/10.7554/eLife.76228

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9363122/
https://www.ncbi.nlm.nih.gov/pubmed/35942681
http://dx.doi.org/10.7554/eLife.76228

Ejemplares similares